High expression levels of MAGEA9 are correlated with unfavorable survival in lung adenocarcinoma

Xiaolu Zhai; Liqin Xu; Siya Zhang; Huijun Zhu; Guoxin Mao; Jianfei Huang

doi:10.18632/oncotarget.6741

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Learn about our FREE

Post-Publication Promotion Services

Rapamycin Press LLC dba Impact Journals is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack... This malicious action will be reported to the FBI.

Research Papers:

High expression levels of MAGEA9 are correlated with unfavorable survival in lung adenocarcinoma

PDF | Full Text | How to cite

Oncotarget. 2016; 7:4871-4881. https://doi.org/10.18632/oncotarget.6741

Metrics: PDF 2161 views | Full Text 3227 views

Xiaolu Zhai1, Liqin Xu2, Siya Zhang1, Huijun Zhu3, Guoxin Mao1, Jianfei Huang3

1Department of Chemotherapy, Nantong University Affiliated Hospital, Nantong 226001, Jiangsu, China

2Department of Respiratory, Nantong University Affiliated Hospital, Nantong 226001, Jiangsu, China

3Department of Pathology, Nantong University Affiliated Hospital, Nantong 226001, Jiangsu, China

Correspondence to:

Guoxin Mao, e-mail: [email protected]

Jianfei Huang, e-mail: [email protected]

Keywords: MAGE-A9, lung adenocarcinoma, immunohistochemistry, prognosis, apoptosis

Received: August 25, 2015 Accepted: November 25, 2015 Published: December 23, 2015

ABSTRACT

A variety of melanoma-associated antigen-A (MAGE-A) protein are commonly detected in lung cancers. Their biological function is not well characterized but may involve cell cycle progression and the regulation of apoptosis. We hypothesized that MAGE-A9 is involved in the regulation of apoptosis. To test this hypothesis, we evaluated MAGE-A9 protein expression by immunohistochemical staining and we assessed the relationship between the expression of MAGE-A9 and clinical pathological parameters. In addition, we investigated the effect of MAGE-A9 down-regulation in lung adenocarcinoma. The results showed that a high expression level of MAGE-A9 protein in lung adenocarcinoma tumor cells was related to larger tumor diameter (P = 0.013) and poor differentiation (P = 0.029). Cox regression analysis revealed that the expression of MAGE-A9 in lung adenocarcinoma tumor cells (P < 0.001) is an independent prognostic factor in five-year survival rates. NSCLC cells with silenced MAGE-A9 had decreased cell proliferation, migration and invasion in cell culture compared to corresponding control cells. The NSCLC cells showing down-regulated MAGE-A9 induced the expression of apoptosis-associated proteins. In addition, MAGE-A9 was associated with resistance to conventional chemotherapeutic agents. Our findings provide evidence that MAGE-A9 could be a potential therapeutic target in NSCLC.

Publication Alerts

Oncoscience

Post-Publication Promotion

Research Papers:

High expression levels of MAGEA9 are correlated with unfavorable survival in lung adenocarcinoma